Patents Assigned to Ferring International Center S.A.
-
Publication number: 20240327487Abstract: Preparations including recombinant FSH (rFSH).Type: ApplicationFiled: March 14, 2024Publication date: October 3, 2024Applicant: Ferring International Center S.A.Inventors: Ian COTTINGHAM, Daniel PLAKSIN, Richard Boyd WHITE
-
Patent number: 11952407Abstract: Preparations including recombinant FSH (rFSH).Type: GrantFiled: April 30, 2021Date of Patent: April 9, 2024Assignee: FERRING INTERNATIONAL CENTER S.A.Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
-
Publication number: 20220323538Abstract: The invention provides methods and dosing regimens for treating metastatic stage prostate cancer in a subject using degarelix, as well as related methods of using degarelix in a subject identified as having metastatic stage prostate cancer, and methods of using degarelix to prevent or delay the progression of locally advanced prostate cancer.Type: ApplicationFiled: May 31, 2022Publication date: October 13, 2022Applicant: FERRING INTERNATIONAL CENTER S.A.Inventor: Bo-Eric PERSSON
-
Publication number: 20220218783Abstract: The invention provides methods and dosing regimens for treating metastatic stage prostate cancer in a subject using degarelix, as well as related methods of using degarelix in a subject identified as having metastatic stage prostate cancer, and methods of using degarelix to prevent or delay the progression of locally advanced prostate cancer.Type: ApplicationFiled: March 31, 2022Publication date: July 14, 2022Applicant: FERRING INTERNATIONAL CENTER S.A.Inventor: Bo-Eric PERSSON
-
Publication number: 20220193052Abstract: The present invention provides a physically and chemically stable pharmaceutical liquid composition including sodium picosulfate, magnesium oxide, citric acid and malic acid and methods of making and using such a composition.Type: ApplicationFiled: December 3, 2021Publication date: June 23, 2022Applicant: Ferring International Center S.A.Inventors: Bong Gil NAM, Byeung Jun LEE, Shunji JIN
-
Publication number: 20200345708Abstract: The present invention provides a physically and chemically stable pharmaceutical liquid composition including sodium picosulfate, magnesium oxide, citric acid and malic acid and methods of making and using such a composition.Type: ApplicationFiled: April 13, 2020Publication date: November 5, 2020Applicant: Ferring International Center S.A.Inventors: Bong Gil NAM, Byeung Jun LEE, Shunji JIN
-
Patent number: 10799423Abstract: A liquid-transfer adapter operatively interposable between an injector and a vial is provided. The liquid-transfer has an injector engaging portion configured for fluidly coupling to an injector and a vial coupling. The vial coupling includes a spike that has a spike axis and a tip portion configured for piercing a septum of a vial. The tip portion includes a plurality of facets that meet each other at one or more edges and at least one of the one or more edges is sloped with respect to the spike axis. The spike defines a channel extending therethrough in fluid communication with the injector engaging portion. A channel opening is defined in at least one of the facets and disposed without interrupting the edges.Type: GrantFiled: October 13, 2017Date of Patent: October 13, 2020Assignee: FERRING INTERNATIONAL CENTER S.A.Inventors: Julius C. Sund, Kevin D. Swanson
-
Publication number: 20200222319Abstract: The present disclosure discloses a process for the continuous manufacture of a liquid pharmaceutical composition, the process comprising providing a mixing unit, feeding a therapeutic agent and a liquid vehicle to the mixing unit, operating the latter thereby mixing the agent and the vehicle into a liquid pharmaceutical composition, discharging the composition into a holding unit.Type: ApplicationFiled: September 17, 2018Publication date: July 16, 2020Applicant: FERRING INTERNATIONAL CENTER S.A.Inventors: Robert RĂ–NNBACK, Josselin SAUNIER
-
Patent number: 10624879Abstract: The present invention provides a physically and chemically stable pharmaceutical liquid composition including sodium picosulfate, magnesium oxide, citric acid and malic acid and methods of making and using such a composition.Type: GrantFiled: November 27, 2017Date of Patent: April 21, 2020Assignee: FERRING INTERNATIONAL CENTER S.A.Inventors: Bong Gil Nam, Byeung Jun Lee, Shunji Jin
-
Patent number: 10611810Abstract: Compounds of the present invention of formula I and formula II are disclosed in the specification and wherein the compounds are modulators of Bone Morphogenic Protein activity. Compounds are synthetic peptides having a non-growth factor heparin binding region, a linker, and sequences that bind specifically to a receptor for Bone Morphogenic Protein. Uses of compounds of the present invention in the treatment of bone lesions, degenerative joint disease and to enhance bone formation are disclosed.Type: GrantFiled: January 31, 2008Date of Patent: April 7, 2020Assignee: FERRING INTERNATIONAL CENTER S.A.Inventors: Paul O. Zamora, Louis A. Pena, Xinhua Lin, Kazuyuki Takahashi
-
Patent number: 9827231Abstract: The present invention provides a physically and chemically stable pharmaceutical liquid composition including sodium picosulfate, magnesium oxide, citric acid and malic acid and methods of making and using such a composition.Type: GrantFiled: July 20, 2016Date of Patent: November 28, 2017Assignee: Ferring International Center S.A.Inventor: Bong Gil Nam
-
Patent number: 9023862Abstract: The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.Type: GrantFiled: November 17, 2014Date of Patent: May 5, 2015Assignee: Ferring International Center S.A.Inventors: Antonio Pellicer-Martinez, Carlos Simon-Valles, Edurne Novella-Maestre
-
Patent number: 8927568Abstract: The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.Type: GrantFiled: February 1, 2008Date of Patent: January 6, 2015Assignee: Ferring International Center S.A.Inventors: Antonio Pellicer-Martinez, Carlos Simon-Valles, Edurne Novella-Maestre
-
Patent number: 8722088Abstract: Compositions, kits, and methods are provided directed to the treatment of prostate cancer using a maintenance dose of degarelix or pharmaceutically acceptable salt thereof, an excipient, and a solvent.Type: GrantFiled: April 30, 2010Date of Patent: May 13, 2014Assignee: Ferring International Center S.A.Inventors: Tine Kold Olesen, Lars Erichsen, Per Cantor
-
Publication number: 20140107197Abstract: A pharmaceutical composition comprising a docusate; an osmotic laxative; and a benzoate.Type: ApplicationFiled: December 20, 2013Publication date: April 17, 2014Applicant: Ferring International Center S.A.Inventors: Klaus Jensen, Soren Halskov, Henning Lund
-
Patent number: 8637570Abstract: A pharmaceutical composition comprising a docusate; an osmotic laxative; and a benzoate.Type: GrantFiled: December 5, 2008Date of Patent: January 28, 2014Assignee: Ferring International Center S.A.Inventors: Klaus Jensen, Soren Halskov, Henning Lund
-
Patent number: 8481083Abstract: Compositions are provided that are useful for the preparation of a medicament. The compositions comprise granules having a layer of sodium picosulphate coated on potassium bicarbonate. Additional granules having a layer of magnesium oxide coated on a core of citric acid are also provided. The two types of granules may be combined to obtain mixtures (preferably homogeneous or substantially homogeneous mixtures) of the two types of granules, which are useful, e.g., as pharmaceutical compositions.Type: GrantFiled: October 10, 2008Date of Patent: July 9, 2013Assignee: Ferring International Center S.A.Inventors: Haijun Xu, Tiejun Diao
-
Patent number: 8450338Abstract: Compositions are provided that are useful for the preparation of a medicament. The compositions comprise granules having a layer of sodium picosulphate coated on potassium bicarbonate. Additional granules having a layer of magnesium oxide coated on a core of citric acid are also provided. The two types of granules may be combined to obtain mixtures (preferably homogeneous or substantially homogeneous mixtures) of the two types of granules, which are useful, e.g., as pharmaceutical compositions.Type: GrantFiled: September 27, 2011Date of Patent: May 28, 2013Assignee: Ferring International Center S.A.Inventors: Haijun Xu, Tiejun Diao
-
Patent number: 8334298Abstract: Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.Type: GrantFiled: April 24, 2006Date of Patent: December 18, 2012Assignee: Ferring International Center S.A.Inventors: Antonio Pellicer-Martinez, Joan-Carles Arce, Carlos Simon-Valles, Raul Gomez-Gallego
-
Publication number: 20120214733Abstract: The present invention relates to oxytocin receptor agonist compounds, pharmaceutical compositions comprising the same, use of such compounds for the manufacture of a medicament for treatment of inter alia, abdominal pain, irritable bowel syndrome (IBS), autism, erectile dysfunction, female sexual dysfunction, labor induction and maintenance, lactation induction and maintenance, postpartum hemorrhage, Post Traumatic Stress Disorder (PTSD), pain, anxiety and other conditions, as well as to methods for the treatment of such conditions, wherein such compounds are administered.Type: ApplicationFiled: September 21, 2010Publication date: August 23, 2012Applicant: FERRING INTERNATIONAL CENTER S.A.Inventors: Kazimierz Wisniewski, Claudio Daniel Schteingart, Sudarkodi Alagarsamy, Robert Galyean